A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

Atrogi AB, a clinical stage biotech company pioneering novel GPCR pathway-signalling modulators to transform metabolic and muscle health, today announces that the first subjects have been dosed in a ...

Researchers reveal how a light-activated drug can change shape and activity at β-adrenergic receptors, enabling precise ...

First-in-class oral therapy ATR-258 mimics the effects of exercise - driving fat loss, increasing muscle, and improving metabolism - with broad potential as a novel treatment for muscle-sparing ...